References
- Shapiro S, Slone D, Lewis GP. et al: Fatal drug reactions among medical inpatients. JAMA 216:467–472, 1971
- Friedman GD, Collen MF. Harris LE. et al: Experience in monitoring drug reactions in outpatients. JAMA 217:567–572. 1971
- Davies PD: Drug-induced lung disease. Br J Dis Chest 63:59–70. 1969
- Gell PG, Coombs RR: Clinical Aspects of Immunology. Ed 2. Oxford, England, Blackwell Scientific Publications Ltd. 1968
- Parker CW: Drug reactions. In Samter M, Alexander HL (Editors): Immunologic Diseases. Boston. Little. Brown & Co. 1965. pp 663–681
- Israel H L, Diamond P: Recurrent pulmonary infiltration and pleural effusion due to nitrofurantoin sensitivity. N Engl J Med 266:1024–1026. 1962
- Hailey FJ. Glascock HW Jr. Hewitt WF: Pleuropneumonic reactions to nitrofurantoin. N Engl J Med 281:1087–1090. 1969
- Rosenow EC III. DeRemee RA. Dines DE: Chronic nitrofurantoin pulmonary reaction: Report of 5 cases. N Engl J Med 279:1258–1262. 1968
- Timmerman JC. Long JP, Pittinger CB: Neuromuscular blocking properties of various antibiotic agents. Toxicol Appl Pharmacol 1:299, 1959
- Lindesmith LA, Baines RD Jr. Bigelow DB. et al: Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med 68:318–327. 1968
- Rose G A, Spencer H: Polvarteritis nodosa. Q J Med 26:43–81. 1957
- Oliner H. Schwartz R. Rubio F. et al: Interstitial pulmonary fibrosis following busulfan therapy. Am J Med 31:134–139. 1961
- Burns WA. McFarland W. Matthews MJ: Busulfan-induced pulmonary disease: Report of a case and a review of the literature. Am Rev Respir Dis 101:408–413, 1970
- Heard BE, Cooke RA: Busulphan lung. Thorax 23:187–193, 1968
- Smalley RV, Wall RL: Two cases of busulfan toxicity. Ann Intern Med 64:154–164, 1966
- Clarysse AM, Cathey WJ. Cartwright GE, et al: Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 209:1861–1868, 1969
- Acute Leukemia Group B: Acute lymphocytic leukemia in children: Maintenance therapy with methotrexate administered intermittently. JAMA 207:923–928, 1969
- Ichikawa T: A statistical observation of bleomycin side effects. Sixth Symposium of Japanese Society for Cancer Therapy. Tokyo, Ishiyaku, 1969
- Perez-Guerra F, Harkleroad LE, Walsh RE, et al: Acute bleomycin lung. Am Rev Respir Dis 106:909–913, 1972
- O'Neill TJ, Kardinal CG, Tierney LM: Reversible interstitial pneumonitis associated with low dose bleomycin. Chest 68:265–267, 1975
- Blum RH, Carter SK, Agree K: A clinical review Of bleomycin—a new antineoplastic agent. Cancer 31:903–914, 1973
- Samter M, Beers RF Jr: Intolerance to aspirin: Clinical studies and consideration of its pathogenesis. Ann Intern Med 68:975–983, 1968
- Vanselow N A, Smith JR: Bronchial asthma induced by indomethacin. Ann Intern Med 66:568–572, 1967
- Stenius BS, Lemola M: Hypersensitivity to acetylsalicylic acid (ASA) and tartrazine in patients with asthma. Clin Allergy 6:119–129, 1976
- Smith LJ, Slavin RG: Drugs containing tartrazine dye. J Allergy Clin Immunol 58:456470, 1976
- Settipane GA, Pudupakkam RK: Aspirin intolerance. III. Subtypes, familial occurrence, and cross-reactivity with tartrazine. J Allergy Clin Immunol 56:215–221, 1975
- Settipane GA, Chafee FH, Klein DE: Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Immunol 53:200–204, 1974
- Hrnicek G, Skelton J, Miller WC: Pulmonary edema and salicylate intoxication. JAMA 230:866–867. 1974
- Graham JR, Suby HI, LeCompte PR. et al: Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med 274:359–368, 1966
- Rosenow EC III: The spectrum of drug-induced pulmonary disease. Ann Intern Med 77:977–991, 1972
- McNeill RS, Ingram CG: Effects of propranolol on ventilatory function. Am J Cardiol 18:473–475, 1966
- Perry HM Jr, O'Neal RM, Thomas WA: Pulmonary disease following chronic chemical ganglionic blockade. Am J Med 22:37–50, 1957
- Peterson AG, Dodge M, Helwig FC: Pulmonary changes associated with hexamethonium therapy. Arch Intern Med 103:285–288, 1959
- Burgher LW, Kass I, Schenken JR: Pulmonary allergic granulomatosis: A possible drug reaction in a patient receiving cromolyn sodium. Chest 66:84–86, 1974
- Lobel H, Machtey I, Eldror MY: Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate. Lancet 2:1032, 1972
- Repo UK, Nieminen P: Pulmonary infiltrates with eosinophilia and urinary symptoms during disodium cromoglycate treatment: A case report. Scand J Respir Dis 57:1–4, 1976
- Brettner A, Heitzman ER, Woodin WG: Pulmonary complications of drug therapy. Radiology 96:31–38, 1970
- Hill RB Jr, Rowlands DT Jr, Rifkind D: Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation. N Engl J Med 271:1021–1027, 1964
- Santini LC, Williams JL: Mediastinal widening (presumably lipomatosis) in Cushing's syndrome. N Engl J Med 284:1357–1359, 1971
- Mahon WE, Scott DJ, Ansell G, et al: Hypersensitivity to pituitary snuff with miliary shadowing in the lungs. Thorax 22:13–20. 1967
- Weill H, Ferrans VJ, Gay RM. et al: Early lipoid pneumonia: Roentgenologic, anatomic and physiologic characteristics. Am J Med 36:370–376, 1964
- Cooke CR, Hyland JW: Pathological calcification of the lungs following intravenous administration of calcium. Am J Med 29:363–368, 1960
- Simon HB, Daggett WM, DeSanctis RW: Hemothorax as a complication of anticoagulant therapy in the presence of pulmonary infarction. JAMA 208:1830–1834, 1969
- Steinberg AD: Pulmonary edema following ingestion of hydrochlorothiazide. JAMA 204:825–827, 1968
- Kaplan Al. Sabin S: Dextran 40: Another cause of drug-induced noncardiogenic pulmonary edema. Chest 68:376–377, 1975
- Bogartz LJ, Miller WC: Pulmonary edema associated with propoxyphene intoxication. JAMA 215:259–262, 1971
- Glauser FL, Smith WR, Caldwell A, et al: Ethchlorvynol (Placidyl)-induced pulmonary edema. Ann Intern Med 84:46–48, 1976
- Frand UI, Shim CS, Williams MH Jr: Methadone-induced pulmonary edema. Ann Intern Med 76:975–979, 1972
- Steinberg AD, Karliner JS: The clinical spectrum of heroin in pulmonary edema. Arch Intern Med 122:122–127, 1968
- Sternlieb I. Bennett B, Scheinberg IH: D-penicillamine induced Good pasture's syndrome in Wilson's disease. Ann Intern Med 82:673–676, 1975
- Eastmond CJ: Diffuse alveolitis as complication of penicillamine treatment for rheumatoid arthritis. Br Med J 1:1506–1507, 1976
- Winterbauer RH, Wilske KR, Wheelis RF: Diffuse pulmonary injury associated with gold treatment. N Engl J Med 294:919–921, 1976